517 related articles for article (PubMed ID: 28060378)
1. CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages.
Murphy PS; Wang J; Bhagwat SP; Munger JC; Janssen WJ; Wright TW; Elliott MR
Cell Death Differ; 2017 Mar; 24(3):559-570. PubMed ID: 28060378
[TBL] [Abstract][Full Text] [Related]
2. Extracellular adenosine produced by ecto-5'-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors Salmonella persistence.
Costales MG; Alam MS; Cavanaugh C; Williams KM
Nitric Oxide; 2018 Jan; 72():7-15. PubMed ID: 29108754
[TBL] [Abstract][Full Text] [Related]
3. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
4. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
5. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
[TBL] [Abstract][Full Text] [Related]
6. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
7. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.
Shuai C; Xia GQ; Yuan F; Wang S; Lv XW
Eur J Pharmacol; 2021 Aug; 905():174198. PubMed ID: 34033815
[TBL] [Abstract][Full Text] [Related]
8. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J
PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090
[TBL] [Abstract][Full Text] [Related]
9. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
10. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
[TBL] [Abstract][Full Text] [Related]
11. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
[TBL] [Abstract][Full Text] [Related]
12. CD73-generated adenosine promotes osteoblast differentiation.
Takedachi M; Oohara H; Smith BJ; Iyama M; Kobashi M; Maeda K; Long CL; Humphrey MB; Stoecker BJ; Toyosawa S; Thompson LF; Murakami S
J Cell Physiol; 2012 Jun; 227(6):2622-31. PubMed ID: 21882189
[TBL] [Abstract][Full Text] [Related]
13. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus.
Guzman-Flores JM; Cortez-Espinosa N; Cortés-Garcia JD; Vargas-Morales JM; Cataño-Cañizalez YG; Rodríguez-Rivera JG; Portales-Perez DP
Immunobiology; 2015 Aug; 220(8):976-84. PubMed ID: 25770019
[TBL] [Abstract][Full Text] [Related]
15. Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection.
Francois V; Shehade H; Acolty V; Preyat N; Delrée P; Moser M; Oldenhove G
Mucosal Immunol; 2015 Jul; 8(4):773-84. PubMed ID: 25389034
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
[TBL] [Abstract][Full Text] [Related]
17. Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.
Zhang W; Zhang Y; Wang W; Dai Y; Ning C; Luo R; Sun K; Glover L; Grenz A; Sun H; Tao L; Zhang W; Colgan SP; Blackburn MR; Eltzschig HK; Kellems RE; Xia Y
Circ Res; 2013 May; 112(11):1466-78. PubMed ID: 23584256
[TBL] [Abstract][Full Text] [Related]
18. Ecto-5'-nucleotidase (CD73) regulates host inflammatory responses and exacerbates murine salmonellosis.
Alam MS; Kuo JL; Ernst PB; Derr-Castillo V; Pereira M; Gaines D; Costales M; Bigley E; Williams K
Sci Rep; 2014 Mar; 4():4486. PubMed ID: 24670982
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
[TBL] [Abstract][Full Text] [Related]
20. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
